← TickerEye

0J8P.LIDEXX Laboratories, Inc.

Stock·LSE·£

£533,53+2.19%
...
Day High£538,34
Day Low£504,08
Volume96

About

IDEXX Laboratories, Inc. is a global enterprise dedicated to creating, producing, and distributing a broad spectrum of products and services. Its primary focus lies in serving the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company delivers crucial solutions across several key areas. For companion animals, IDEXX offers comprehensive veterinary diagnostic tools, including in-clinic point-of-care instruments, consumables, and rapid assay test kits. They also provide expert veterinary reference laboratory diagnostics, consulting services, and advanced practice management and diagnostic imaging systems. Beyond pets, their portfolio extends to health monitoring and diagnostic products vital for livestock, poultry, and dairy farming. In the water quality segment, IDEXX manufactures tests designed to detect various microbiological contaminants, ensuring safety and compliance, with notable examples like the Colilert, Enterolert, and Legiolert tests. IDEXX also serves the biomedical research community with health monitoring and laboratory animal diagnostic instruments and services. Furthermore, they contribute to human point-of-care medical diagnostics by providing specialized electrolytes and blood gas analyzers, alongside SARS-CoV-2 RT-PCR solutions. Their extensive product lineup features various in-clinic chemistry, blood, and urine analyzers (such as the SediVue Dx), hematology systems, and rapid diagnostic assays like SNAP test kits. Complementing these offerings, the company provides essential veterinary software solutions for both independent and corporate veterinary practices. Sales and distribution are managed through their dedicated marketing, customer service, sales, and technical support teams, supplemented by a network of independent distributors and other resellers. Established in 1983, IDEXX Laboratories, Inc. maintains its headquarters in Westbrook, Maine.

www.idexx.com

Key Statistics

Market Cap
42.09B
EPS
13.17
Dividend Yield
0.00%
Beta
1.54
P/B
34.09
Return on Equity
66.0%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky
Employees
11,000
IPO Date
2018-01-19
Country
US

Track live with TickerEye

See 0J8P.L price live on your physical desk display. Set alerts with iOS & Android apps.